abstract: miR-30d is known to be up-regulated during the acquisition of receptivity in the endometrium. In order to determine the transcriptomic and proteomic changes which occur after transient overexpression of miR-30d in primary endometrial epithelial cells, in vitro cultured human endometrial epithelial cells (hEECs) were studied experimentally. Two different miRNAs (scramble versus mimic; n ¼ 15) were transiently transfected into primary hEECs from four different patients and were evaluated for mRNA and protein expression using Agilent's gene expression microarray and iTRAQ analysis techniques, respectively. A set of differentially expressed mRNAs were validated by qPCR and several differentially expressed proteins were validated by western blot. Finally, methylation differential immunoprecipitation (MeDIP) was used to validate the epigenetic changes in the H19 gene. The results showed that transient transfection with miR-30d miRNA induced the differential mRNAexpression of 176 genes (75 up-regulated and 101 down-regulated). Several of them have been associated with reproductive and endocrine system disorders, tissue development, and are implicated in epithelial cell proliferation. Also, the down-regulation of some genes such as H19 and N-methyltransferase (NNMT) may suggest that epigenetic alterations are induced. Furthermore, upstream effects of genes regulated by the estrogen receptor alpha 1 (ESR1) transcription factor have been predicted. Proteomic analysis identified 2290 proteins, of which 108 were differentially expressed (47 up-regulated and 61 down-regulated). Among these differentially expressed proteins DNA methyl transferase (DNMT)1 was found to be up-regulated; this protein participates in the maintenance of DNA methylation, supporting an epigenetic role for miR30d. Finally MeDIP showed an increase in methylation in the H19 DMR region. In conclusion transient in vitro overexpression of the receptivity-upregulated miRNA miR-30d in hEECs seems to activate genes which are associated with hormonal response and the epigenetic status of these cells.
Introduction
MicroRNAs (miRNAs) were first described two decades ago (Lee et al. 1993; Wightman et al. 1993) . Since then, the number of miRNAs described, their cellular content, diversity, functions, has exponentially increased (Ambros 2004; Bartel 2004) together with their interest to the research community.
MiRNAs are transcribed and processed from pri-miRNAs into premiRNAs and finally into the mature miRNA. In order to exert its function, mature miRNA is incorporated into the RNA-induced silencing complex (RISC) which aligns it to the 3 ′ -UTR complementary region of its specific target-mRNA, inhibiting target translation and/or promoting its degradation (Jackson and Standart 2007; Nilsen 2007; Pillai et al. 2007; Moreno-Moya et al. 2013) . Complementary binding is established in 6-7 nt seed regions. The complexity of the system is further increased because miRNAs are able to target hundreds of genes, and a single gene can be targeted by several miRNAs. Moreover, since miRNAs can affect transcription factors these molecules act as transcriptional regulators of gene expression. The endometrium is a complex tissue which lines the uterine cavity and must become receptive to allow the adhesion of the blastocyst during the window of implantation (WOI). The transcriptomic (Carson et al. 2002; Kao et al. 2002; Borthwick et al. 2003; Riesewijk et al. 2003; Horcajadas et al. 2004; Mirkin et al. 2005; Critchley et al. † Both authors contributed equally to this work.
2006; Franchi et al. 2008; Kuokkanen et al. 2010; Tseng et al. 2010; Diaz-Gimeno et al. 2011 , proteomic (Dominguez et al. 2009 ) and lipidomic (Berlanga et al. 2011; Vilella et al. 2013 ) regulation of the human endometrium have been extensively investigated and described by our group and others.
Recently, efforts have been made to describe the miRNA profile during the receptive stage of the human endometrium (Kuokkanen et al. 2010; Sha et al. 2011; Altmae et al. 2013) . These studies reported different profiles, but in all of them 'miR-30d' and 'miR-30b' were consistently up-regulated during the aquisition of endometrial receptivity compared with expression in the pre-receptive stage. However, none of these studies further explored the transcriptomic effects of any of these miRNAs specifically in the development of the WOI. In this work we aimed to investigate the transcriptomic and proteomic effects of the up-regulation of miR-30d in the endometrial epithelium.
In general, the miR-30 family is ubiquitously expressed in humans and has been associated with several functions in different cell types and organisms. They have been determined to participate in epithelial-tomesenchymal transition (Ozcan, 2009) , to confer epithelial phenotypes on human pancreatic cells (Joglekar et al., 2009) , and to regulate apoptosis through both TP53 targeting and via the mitochondrial fission machinery (Li et al., 2010) ; they are negative regulators of bonemorphogenic protein (BMP)-2-mediated osteogenic differentiation (Wu et al., 2012) and also seem to participate in endothelial cell behavior during angiogenesis (Bridge et al., 2012) and in cardiac function (Pan et al., 2013) . Knowledge of their roles in the endometrium is still lacking; however, this microRNA has been shown to participate in trophoblast specification during embryonic development by targeting embryonic ectoderm development protein (Song et al., 2011) .
Materials and Methods

Ethics statement
This study was approved by the Institutional Review Board and Ethics Committee of the Instituto Universitario-Instituto Valenciano de Infertilidad (Universidad de Valencia, Spain) (1204-C-102-FV-F). Informed written consent was obtained from each patient prior to tissue collection.
Patient recruitment for endometrial biopsies and primary human endometrial epithelial cell cultures
Endometrial biopsies were obtained at day LH+0 from patients (18-to 35-year-old) with regular menstrual cycles (n ¼ 4 for microarrays; n ¼ 4 for iTRAQs; n ¼ 4 for qPCRs; n ¼ 3 for western blots; Total n ¼ 15), with normal karyotypes, good general health and a BMI of 19-29 Kg/m 2 who were allocated for controlled ovarian stimulation (COS) for oocyte donation. Biopsies were obtained before the COS treatment. Three additional biopsies were obtained at LH+7 from women under natural cycles. Presence or absence of endometriosis was demonstrated by laparoscopy and endometritis was also excluded. All patients gave informed consent prior to entering the study. The COS protocol was carried out by following a GnRH-agonist long protocol with 200 IU recombinant follicle stimulating hormone (FSH; Gonal F; Merck-Serono). When six or more follicles were .17 mm in diameter, recombinant chorionic gonadotrophin (rCG; Ovitrelle; Merck-Serono) was administered to trigger ovulation. Doses were adjusted according to the ovarian response as judged by serum estradiol concentrations and ultrasound scans every 3 days.
The biopsies were processed to separate the epithelial and stromal fractions by collagenase digestion and gravity sedimentation, as previously reported by our group (Simon et al. 1997) . The purified human endometrial epithelial cells (hEECs) were plated at 10 -20% confluency and maintained in culture until the experiments were performed.
Transient microRNA transfection of primary hEECs
When hEEC cultures reached 50% confluency, the cells were transiently transfected with 50 nM of either miR-30d mimic or scramble miRNA using HiPerfect, following the manufacturer's instructions (Qiagen, Valencia, CA, USA); after 72 h RNA was extracted from the cells. To ensure that the miRNA fraction was recovered we performed RNA extraction using the miRNeasy Kit (Qiagen). The RNA extracted was quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific, Inc., MA, USA) and the quality of RNA samples was assessed using a Nano LabChip BioAnalyzer 2100 (Agilent Technologies, Inc., DE, USA).
MiScript qPCR for transfection efficiency
To evaluate the transfection efficiency, basal levels of miR-30d in hEEC cultures (compared with the housekeeping gene SNORD96) were measured by quantitative RT-PCR with the miScript reverse transcription kit, miScript SYBR Green PCR kit and miScript primer assays according to the manufacturer's recommendations (Qiagen).
Transcriptomic microarray analysis
The hEEC transcriptomes, transfected under two different conditions (scramble or mimic; n ¼ 4), were subjected to Agilent GE 4 × 44K Human v2 microarrays (Agilent Technologies, CA, USA). Total RNA from each sample was processed according to manufacturer's microarray instructions, scanned, and the data obtained for each probe was normalized and log2 transformed using R software and libraries from the Bioconductor database (http://www. bioconductor.org/). The web-based Babelomics tool (http://babelomics. bioinfo.cipf.es/) was used on the resulting data matrix to merge the replicates from each probe by the mean. The data were then analyzed using the Rank Products module in the MeV software for statistical analysis.
Validation
For microarray validation, an independent set of four samples under two experimental conditions was obtained by quantitative real-time PCR, in triplicate, using LightCycler FastStart DNA Master SYBR green I in a LightCycler 480 (Roche Applied Science, USA). The selected genes were H19, BMP4 and FOS, their mRNA level was normalized to the housekeeping gene GAPDH and the fold change was estimated using the 22DDCt formula. The primer sequences used were: GAPDH, 5
′ -GAAGGTGAAGGTCGG AGTC-3 ′ and 5
′ -GGAGCTTCCACCACGAAGAA-3 ′ and 5 ′ -GGAAGCCCCTT TCCCAATCA-3 ′ ; and FOS, 5 ′ -GGGGCAAGGTGGAACAGTTA-3 ′ and 5
′ -AGGTTGGCAATCTCGGTCTG-3 ′ .
Bioinformatic analysis of the deregulated genes
Firstly the mRNAs identified were functionally studied in silico by computational analysis of the biological processes and pathways that they affected the most, using the IPA software (Ingenuity w Systems). This software implements an algorithm which finds interactions and associations with processes previously reported in the literature. This tool was able to predict the 'physiological system development and functions', 'molecular and cellular functions' and 'diseases and disorders' affected; it also finds potential upstream regulators that might direct the deregulation pattern of differentially expressed genes, miR-30d transcriptomic and proteomic effects in hEECs and that may stimulate significant inactivation (a z-score less than 22) or activation (z-score more than 2). To identify potential miRNA target genes, we used Targetscan (http://www.targetscan.org/) a publicly available target prediction algorithm.
Proteomic iTRAQ 8-plex analysis
Four primary hEEC samples under two experimental conditions were lysed and 100 mg of each isolated protein mixture was loaded onto a 1D PAGE gel without resolving the mixture. Each lane was cut and digested overnight (o.n.) at 378C with sequencing-grade trypsin (Promega) as previously described (Shevchenko et al., 1996) . The reaction mixtures were dried in a speed vacuum. Each sample was re-dissolved in 80 ml of TEAB-ethanol solution (3/7; v/v), was sonicated for 10 min, added to the appropriate iTRAQ Reagent vial, and vortexed thoroughly. Each sample vial was immediately rinsed with an additional 20 ml of TEAB-ethanol solution and incubated at room temperature (r.t.) for 3 h. All samples were combined into a single tube and dried by vacuum centrifugation. Two hundred micrograms of the peptide mixture was dissolved in 225 ml of 7 M urea/2 M thiourea/1.6% ampholytes. One IPG strip (GE; 11 cm, pH 3 -11 NL) was hydrated with the peptide solution o.n. at r.t. and the peptides were isoelectrofocused with 5000 -25000 Vh. After focusing, the strip was washed with milliQ-grade water, and cut into 11 equal pieces. The peptides were extracted with 100 ml each of three solutions (5% ACN, 0.1% TFA; 50% ACN, 0.1% TFA; 100% ACN 0.1% TFA). All the peptide fractions were combined, dried by vacuum centrifugation and re-dissolved in 20 ml of 2% CAN, 0.1% TFA. The final peptide concentration was determined by measuring the absorbance at 280 nm using a NanoDrop instrument.
For the colored peptide solutions an exploratory liquid chromatographytandem mass spectrometry (LC-MS/MS) analysis was performed in order to determine the optimum amount to be injected into the column. LC-MS/MS was carried out as follows: 5 ml of each sample was loaded onto a trap column (Nano LC Column, 3 m C18-CL, 75 mm × 15 cm; Eksigent) and desalted with 0.1% TFA at 3 ml/min for 5 min. The peptides were then loaded onto an analytical column (LC Column, 3 m C18-CL, 75 mm × 12 cm, Nikkyo Technos) equilibrated in 5% acetonitrile and 0.1% FA (formic acid). Elution was carried out with a linear gradient of 35% B in A for 90 min (A: 0.1% FA; B: ACN, 0.1% FA) at a flow rate of 300 nl/min. Peptides were analyzed in a nano-ESI QqTOF mass spectrometer (5600 TripleTOF, ABSCIEX). The triple time of flight (TOF) was operated in 'information-dependent' acquisition mode, in which a 0.25 s TOF-MS scan from 350 to 1250 m/z was performed, followed by 0.075 s product-ion scans from 100 to 1500 m/z on the 25 most intense 2-5 charged ions. ProteinPilot's default parameters were used to generate a peak list directly from 5600 TripleTOF wiff files, and their Paragon algorithm was used to search the Expasy protein database with the following parameters: iTRAQ QUANTIFICATION, trypsin specificity, cys-alkylation (IAM), taxonomy restricted to 'human' and the search-effort set to 'rapid'. To avoid using the same spectral evidence in more than one protein, the identified proteins were grouped based on MS/MS spectra by the ProteinPilot Pro Group algorithm. Thus, proteins sharing MS/MS spectra are grouped regardless of the peptide sequence they are assigned. The protein within each group that can explain more spectral data with confidence is shown as the primary protein in the group. Only proteins in the group for which there is individual evidence (unique peptides with enough confidence) are also listed with a different list number, usually towards the end of the protein list.
Western blotting
For western blot validation, an independent set of three samples under the two experimental conditions were lysed in ice-cold buffer containing 300 mM NaCl, 20 mM Tris, 10 mM EDTA, 2% (v/v) Triton X-100, pH ¼ 7.3 supplemented with a protease inhibitor cocktail (Roche Applied Science, USA) and 10 mM PMSF (Sigma-Aldrich, USA). Protein quantification was performed using the Bradford assay. Next, 25 mg/lane of protein extracts from the cell lysates were separated on 10% SDS-polyacrylamide gels, transferred to polyvinylidene difluoride membranes (BIO-RAD, CA, USA) and incubated overnight at 48C with antibodies specific to human DNMT1 (Abcam, UK, ab19905), ALDH2 (Abcam, UK, ab54828), WNT1 (Abcam, UK, ab15251), PGRMC1 (Santa Cruz, sc-271275) and b-ACTIN as a housekeeping control (Santa Cruz, sc-47778). After washing three times, the blots were incubated with diluted horseradish peroxidaseconjugated secondary antibodies (Santa Cruz Biotechnology, St. Cruz, CA, USA) for 1 h at r.t. Blots were then washed extensively and developed using enhanced chemiluminescence. Densitometry analysis of the gels was carried out using the ImageJ software (http://rsbweb.nih.gov/ij/links.html) and each western blot was normalized to the housekeeping protein band to correct for differences during sample loading.
Methylated DNA immunoprecipitation
Genomic DNA was extracted from three different scramble-or mimic-30d-treated hEECs, sonicated into fragments ranging in size from 200 to 1000 bp, and divided into input (non-immunoprecipitated) and immunoprecipitated portions as recommended by the manufacturer (Abnova Corporation, Taiwan). The immunoprecipitated DNA was incubated with anti-5-methylcytosine monoclonal antibody to bind methylated DNA. Methylated DNA was subjected to quantitative real-time PCR as previously mentioned for the H19 DMR region (paternally methylated and maternally expressed) and the UBE2B (typically unmethylated) genes (Movassagh et al., 2010) . To evaluate the relative enrichment of target sequences after methylated DNA immunoprecipitation (MeDIP), we estimated the fold change using the 22DDCt formula, normalizing against input DNA. The primers used were: UBE2B, 5
Statistical data analysis
For primary hEEC gene expression microarrays, the matrix containing the logtransformed, normalized and merged-by-probe data was introduced into the Rank Product module in the MeV software for statistical analysis. Samples were assigned to 'Mimic 30d-' or 'Scramble-treated' groups and were compared. A false discovery rate (FDR) correction of ,5% was used, and miRNA fold changes between the different samples and groups were calculated. For supervised hierarchical clustering heat map representation, only the intensity values for the set of differentially expressed genes were standardized. For proteomic analysis, a data matrix with areas of each peptide identified was log-transformed, normalized using quantile normalization and merged by the mean in the R software. The data were subjected to Rank product analysis with a FDR of ,5%, and were corrected in the MeV software to obtain the final list of differentially expressed proteins.
The data presented in box plots represent the minimum, first quartile, median, second quartile and maximum values. Bar graphs are expressed as means plus or minus the standard error of the mean. Pairwise comparisons between conditions were performed using the Mann-Whitney U-test for continuous variables, and P-values ≤0.05 were considered as statistically significant.
Results
MiR-30d is expressed in the epithelial compartment of the receptive endometrium Although mir-30d was previously described as up-regulated during the acquisition of endometrial receptivity (Kuokkanen et al., 2010; Sha et al., 2011; Altmae et al., 2013) , we wanted to determine which cell compartment it is up-regulated in. Three biopsies from healthy patients during a natural cycle were obtained and the stromal cells from epithelial cells were mechanically and enzymatically separated followed by MiScript qPCR for hsa-miR-30d to assess the expression of miR-30d in these two compartments during the receptive phase (seven days after the luteinizing hormone peak; LH+7). Hsa-miR-30d expression was increased by 2.65 + 0.69 fold in the epithelial versus the stromal endometrial fraction (Fig. 1a) .
The transcriptomic effect of miR-30d transfection in primary hEECs
First we checked the transfection efficiency in primary hEEC cultures with mimic-30d versus scramble miRNAs, showing an 89.95 + 47.23 fold increase in miR-30d after the intervention (Fig. 1b) . A rank product analysis was performed with a FDR of ,5%, and 176 genes were identified as Figure 1 Continued differentially regulated after miR-30d transfection. A total of 75 upregulated and 101 down-regulated genes were registered (Table I) . A standardized supervised hierarchical clustering heat map (Fig. 1c) together with a 3D principal component analysis (PCA; Fig. 1d ) illustrates the different gene expression levels between the two conditions we investigated, and how they cluster together. These results were validated using real-time qPCR for three representative genes (BMP4, H19 and FOS) that were down-regulated in mimic-versus scramble-treated hEECs (Fig. 1e) .
Bioinformatic analysis of genes regulated by miR-30d in hEECs
IPA software analysis allows us to predict the most implicated functions for the set of 51 genes that are differentially regulated by miR-30d. For diseases and disorders the most represented term was cancer, but there were also genes related to the reproductive and endocrine systems (Fig. 2a) . At the molecular and cellular functions level most of the genes were involved in cell proliferation (Fig. 2b) . The physiological system development and functions level the genes appeared to be related to embryonic and tissue development (Fig. 2c) . Based on the literature, the IPA software looks for significant interaction network nodes that are indirectly affected by fourteen differentially expressed genes. These nodes are 'all-trans retinoic acid' (Tice et al., 2002) and 'b-estradiol' (Symmans et al., 2005) , which are described as essential for cell division in epithelial, stromal and myometrial cells; these two nodes, together with 'MYC' (Koch et al., 2007) and 'CTNNB1' (Shimoyama et al. 1999) , are related to proliferation of pancreatic progenitor cells and beta islet cells (Fig. 2d) . The IPA software was also able to predict the potential upstream regulators ESR1 and STAT5B, which reached an activation z-score of less than 22 (an inhibited state), and KDM5B and NUPR1, which achieved a z-score of more than 2 (an activated state), where values above or below these scores are considered to be statistically significant. ESR1 (estrogen receptor alpha) was the closest to the threshold value, and target genes for this transcription factor are BMP4, CSF2, EGR1, FBLN1, FOS, FOXM1, H19, NOTCH3, RPRM and SNAI2 (Fig. 2e) . (Fig. 3a) together with a 3D PCA (Fig. 3b) illustrates the different protein levels between samples and how they cluster together. Western blots for DNMT1, ALDH2, PGRMC1 and WNT1 were used to validate these iTRAQ results (Fig. 3c) , and DNMT1 and ALDH2 were statistically significative (*P-value , 0.05) after MannWhitney U-test.
The genes and proteins which overlapped between transcriptomic and proteomic profiles are illustrated in a Venn diagram (Fig. 3d) , where only ALDH2 was identified as differentially down-regulated at both the mRNA and protein levels. This gene has also been predicted to be directly targeted by hsa-miR-30d (Fig. 3e, seed region) .
The methylation status of the H19 gene
Focusing on the probable regulation of the DNMT1 protein and H19 gene (which is typically methylated) by miR-30d, as suggested by miR-30d overexpression, we hypothesized that alteration of the H19 methylation status might lead to its silencing. This gene, which has been shown to be down-regulated in mimic conditions, is a well-known hemi-methylated gene in the imprinted control region (ICR ; Fig. 4a) ; hence we performed a MeDIP analysis to assess its global methylation status. We selected UBE2B as an unmethylated housekeeping gene to validate the effectiveness of the MeDIP (Fig. 4b) . A statistically significant increase in the methylation status of H19 was observed for mimic-versus scramble-treated hEECs (Fig. 4c) reinforcing the concept that miR-30d modifies not only the transcriptome but also the epigenome of hEECs.
Discussion
Previous studies have reached a consensus on the up-regulation of miR-30d during the receptive phase of the endometrium (Kuokkanen et al. 2010; Sha et al. 2011; Altmae et al. 2013) . Our results indicate that miR-30d was enriched mainly in the epithelial compartment, which is the first cell type that the embryo comes into contact with during implantation. To learn how miR-30d participates in the transition to a receptive phenotype, we transiently overexpressed this miRNA in hEECs in vitro by transfecting the endometrial epithelial cells, with synthetic 'mimic' or 'scramble' miRNAs. Since we decided to explore miRNA effects in primary cells instead of endometrial cell lines, it is important to understand that samples were derived from LH+0 (nonreceptive) biopsies from donor patients before the COS protocol was initiated. The samples were in vitro cultured, potentially differing from the in vivo physiological LH+0 status, but were not affected by hormonal treatments given to the patients.
Some of the genes regulated by this miRNA were very interesting and were chosen for validation. These genes were BMP4, which has been associated with decidualization, is expressed in endometrial epithelium during pregnancy and is widely described as a secretion factor essential for embryonic differentiation to trophoblast lineages (Xu et al., 2002; Stoikos et al., 2008) ; H19 (Fig. 2c) , an mRNA which is not translated into protein but whose deregulation is usually associated with endometrial hyperplasia (Tanos et al. 2004) , implantation failure and DNA methylation impairment (Korucuoglu et al. 2010) ; and FOS (Fig. 2c) , an essential gene associated with endometrial cell proliferation driven by b-estradiol, and which is reported to be down-regulated during the WOI (Fujimoto et al. 1995; Kao et al. 2002) .
The ectopic overexpression of miR-30d in hEECs affects genes that have been associated with cancer, and with reproductive and endocrine system disorders. b-Estradiol is an essential hormone for endometrial proliferation whose actions are modulated when the secretory stage is reached (Owen, 1975) , suggesting that miR-30d might modulate the action of b-estradiol. All-trans retinoic acid can also target different genes to modulate local b-estradiol inactivation in the endometrium (Wang et al., 2011) . Both MYC and FOS gene transcription are rapidly activated by b-estradiol and its presence stimulates cell cycle progression (Cheng et al., 2008) . However, it remains to be determined if all these elements cause changes in mir-30d levels per se or are as a consequence of these changes. Figure 3e shows potential upstream regulators that might confer transcriptomic effects, thus explaining the deregulation of these differentially expressed genes. ESR1 had an activation z-score of less than 22, indicating that it may have a significant gene-inactivating ability. The effect of ESR1 is likely to take place at the transcription factor activation level rather than at the production level because the amount of mRNA did not change. Inactivation of ESR1 would lead to down-regulation of BMP4, EGR1, FOS and H19, as previously reported (Adriaenssens et al. 1999; Eger et al. 2000; Giacomini et al. 2009; Kim et al. 2011) .
Proteomic analysis identified 2290 proteins, the majority being cytoplasmic rather than transmembrane proteins, because the cell membrane precipitation fraction was not analyzed. After rank product analysis, 108 proteins were differentially expressed between the mimic and scramble conditions. Several up-regulated proteins are relevant to endometrial physiology such as: LGALS1, also called galectin-1, a glycoprotein which has been shown to be up-regulated during the miR-30d transcriptomic and proteomic effects in hEECs late-secretory stage in human endometrium, and which seems to be implicated in immune tolerance and embryo implantation (von Wolff et al., 2005; Jeschke et al., 2009; Tirado-Gonzalez et al., 2013) ; MIF, a pro-inflammatory cytokine which has been observed in pre-decidualized stromal cells and in glandular epithelia (Arcuri et al., 2001) ; DNMT1, which has been reported not to change at the mRNA level throughout the menstrual cycle (Vincent et al., 2011) ; and COX6C, which has been reported to be involved in uterine leiomyoma (Kurose et al., 2000) . We also found some proteins relevant for endometrium physiology among the down-regulated proteins, including WNT1, which regulates the balance between estrogen-induced proliferation and progesteronemediated differentiation in normal endometrium (Wang et al., 2009) ; the aldehyde dehydrogenase enzymes (ALDH2 and ALDH1B1) which have been associated with endometrial cancer (Laniewska-Dunaj et al., 2013 , specifically ALDH2, which was the only molecule which was down-regulated at both the protein and mRNA levels (Fig. 3d) , and interestingly, is also a predicted direct target of hsa-miR-30d (Fig. 3e) ; PGRMC1, a type of progesterone receptor that is abundant in the endometrium during the proliferative phase and is localized in the nucleus, but whose function remains to be fully explored (Pru and Clark 2013) ; NOTCH4, a transmembrane receptor that has shown to be down-regulated during the change from the proliferative to the secretory phase in normal human endometrium (Cobellis et al. 2008) ; and ITGAV, an essential receptor which mediates cell adhesion and embryo implantation (Erikson et al. 2009 ).
The down-regulation of H19 imprinted-gene non-coding RNA and the up-regulation of the DNMT1 protein (which is responsible for the maintenance of DNA methylation) may result from epigenetic regulation of the H19 methylation pattern. The global methylation status of a gene can be studied using a MeDIP approach, which enriches the gene of interest in the two conditions (mimic versus scramble). Using this type of analysis we showed that H19 methylation was elevated in mimic-treated hEECs versus scramble controls (Fig. 4c) . Given this interesting result in this well-known hemi-methylated gene, it would be very interesting to analyze CpG sites, which may be enriched or differentially methylated throughout the whole genome, using microarrays or sequencing technologies to assess if miR-30d indirectly affects DNMT1, thus altering the global methylation patterns. Another interesting observation was the down-regulation of the nicotinamide N-methyltransferase gene (NNMT) whose expression has been described to reduce the cellular methylation potential. Therefore given that mimic treatment downregulates this gene, this could increase the global methylation potential (Ulanovskaya et al. 2013) .
Finally, the miR-30 family has been shown to inhibit the epithelialmesenchymal transition by down-regulating some genes, such as SNAI1, and increasing expression of others such as e-cadherin (Zhang et al., 2012) -a gene that is also activated by DNMT1 (Espada et al., 2011) . These observations would explain the maintenance of the epithelial phenotype in primary hEECs in vitro. Another point that merits further research is that postulated alterations to the methylation pattern of the ESR1 promoter would lead to a reduced response to estrogens in the endometrium (Shiozawa et al., 2002; Vincent et al. 2011) , especially interesting because the down-regulation of several genes (FOS, BMP4, H19 and EGR1) indirectly predicts ESR1 inactivation. Further investigation will be required to discover how DNMT1 is indirectly up-regulated by hsa-miR-30d. Figure 4d represents these potential interactions and the working hypothesis presented in this article.
In conclusion, transient in vitro overexpression of miR-30d in primary hEEC cultures seems to regulate genes and proteins involved in proliferation, hormonal responses and methylation status, which highlights another suspected level of regulation exerted by this molecule.
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